A HUMAN SPERM ANTIGEN AS AN IMMUNOCONTRACEPTIVE
A HUMAN SPERM ANTIGEN AS AN IMMUNOCONTRACEPTIVE
批准号:
3843078
负责人:
MICHAEL G O'RAND
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Escherichia coli active immunization antiserum biological models chimeric proteins complementary DNA contraceptives egg /ovum epitope mapping female fertility immunology human genetic material tag human tissue immunopathology in vitro fertilization laboratory mouse laboratory rabbit northern blottings nucleic acid sequence protein sequence sperm surface antigens synthetic peptide synthetic vaccines
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This application addresses the problem of prefertilization
immunocontraception from the perspective of a defined mammalian sperm
surface component and its role in achieving contraception by the antigen's
specific antibody interfering with sperm-zona binding. This study will
utilize a defined human sperm antigen (hspa18) whose function is to bind
human spermatozoa to the zona pellucida. This proposal is organized into
six specific aims to address the molecular biology of the antigen and the
immunological aspects of preventing fertilization. The specific aims are:
I. The human sperm antigen hspa18 will be characterized by sequencing the
human cDNA and the sequence confirmed by partial sequencing of the native
molecule. II. The tissue specificity of hspa18 will be determined by
Northern blot analysis of RNA from various human and primate organs using
the cDNA as a probe. Additionally, a fusion protein to hspa18 will be
produced in E. coli. III. Hspa18 has been characterized by the monoclonal
antibody MA-51 which inhibits sperm penetration into zona-free hamster
oocytes. Therefore, the MA-51 epitope in the hspa18 sequence will be
determined. A synthetic peptide of the MA-51 epitope on hspa18 will be
made and coupled to KLH for immunization of female mice. IV. The
analogous hspa18 antigen in mice has been identified by polyclonal
antisera. It will be sequenced from a mouse testis cDNA library to provide
a comparative sequence whose fusion protein can be tested as an
immunocontraceptive. The mouse model will allow any immunopathological
effects to be evaluated. V. Female mice will be actively immunized with
the fusion protein from AIM 2, with the synthetic peptide(s) from AIM 3,
and with the fusion protein of the mouse antigen sequenced in AIM 4. After
insemination, their fertility will be determined. Control mice will be
actively immunized with the fusion protein which does not contain the
hspa18 or mouse antigen insert molecule (B-galactosidase only) or KLH only.
VI. Antisera produced by the females will be used to determine if mouse
fertilization in vitro is inhibited.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A HUMAN SPERM ANTIGEN AS AN IMMUNOCONTRACEPTIVE
-
批准号:3735611
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL G O'RAND
-
依托单位:
A HUMAN SPERM ANTIGEN AS AN IMMUNOCONTRACEPTIVE
-
批准号:3779289
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL G O'RAND
-
依托单位:
A HUMAN SPERM ANTIGEN AS AN IMMUNOCONTRACEPTIVE
-
批准号:5212796
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL G O'RAND
-
依托单位:--
A HUMAN SPERM ANTIGEN AS AN IMMUNOCONTRACEPTIVE
-
批准号:3757360
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL G O'RAND
-
依托单位:
A HUMAN SPERM ANTIGEN AS AN IMMUNOCONTRACEPTIVE
-
批准号:3857830
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL G O'RAND
-
依托单位:
海外基金